Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Código QR

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Craig Karson,1 Ruth A Duffy,2 Anna Eramo,3 Anna-Greta Nylander,4 Steve J Offord5 1CNK Consultants, Delray Beach, FL, 2Medical Affairs – Neuroscience, Otsuka America Pharmaceutical, Inc., Princeton, NJ, 3Medical Affairs & Phase IV Clinical Affairs, Lundbeck LLC, Deerfield, IL, USA;...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	cognition first-episode psychosis long-term outcome relapse remission schizophrenia Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ed9f8cc055374076827f5e2c74dd0a90
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
por: Nigel Ian Ming Chong, et al.
Publicado: (2021)

Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
por: Suguru Nakajima, et al.
Publicado: (2021)

Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Ryan Sai-Ting Chu, et al.
Publicado: (2021)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Ping Yin, et al.
Publicado: (2021)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
por: Lei Chen, et al.
Publicado: (2021)

Investigaciones en rehabilitación cognitiva para pacientes con esquizofrenia (2004-2013): una revisión temática en beneficio de propuestas para etapas iniciales del trastorno
por: Loubat O,Margarita, et al.
Publicado: (2014)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu C, et al.
Publicado: (2020)

Clinical Features of First-episode Psychoses During the COVID-19 Pandemic
por: Vladimir A. Zyablov, et al.
Publicado: (2021)

Verbal memory improvement in first-episode psychosis APOE-ε4 carriers: a pleiotropic effect?
por: Vila-Rodriguez F, et al.
Publicado: (2017)

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia
por: Liu Y, et al.
Publicado: (2021)

Factors of long-term remission formation in patients with alcohol dependence
por: O. V. Petrunko, et al.
Publicado: (2017)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Rachael K. Blackman, et al.
Publicado: (2022)

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia
por: She S, et al.
Publicado: (2019)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2021)

Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia
por: Dariusz Juchnowicz, et al.
Publicado: (2021)

Perceived stress, quality of life, and coping skills among patients with schizophrenia in symptomatic remission
por: Sheikh Shoib, et al.
Publicado: (2021)

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression
por: Ni P, et al.
Publicado: (2021)

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients
por: Galińska-Skok B, et al.
Publicado: (2019)

Neurocognition and Social Cognition— Possibilities for Diagnosis and Treatment in Ultra-High Risk for Psychosis State
por: Katarzyna Rek-Owodziń, et al.
Publicado: (2021)

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia
por: Ohnishi T, et al.
Publicado: (2021)

THE CORRELATION BETWEEN FAMILY SUPPORT AND RELAPSE IN SCHIZOPHRENIA AT THE PSYCHIATRIC HOSPITAL
por: Rostime Hermayerni Simanullang
Publicado: (2018)

Empathy and Its Relationship With Social Functioning in Individuals at Ultra-High Risk for Psychosis
por: Daan Jan Kuis, et al.
Publicado: (2021)

EFFECTIVE THERAPEUTIC INTERVENTIONS TO PROMOTE RECOVERY FROM FIRST PSYCHOTIC EPISODE AND MINIMIZE ITS RELAPSE: A QUALITATIVE STUDY FROM PAKISTAN
por: Rehana Khalil, et al.
Publicado: (2021)

Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients
por: Rao D, et al.
Publicado: (2019)

Basic auditory processing and emotion recognition in individuals at clinical high risk for psychosis
por: Michael S. Kraus, et al.
Publicado: (2022)

Long-Term Safety and Efficacy of Subcutaneous Cladribine Used in Increased Dosage in Patients with Relapsing Multiple Sclerosis: 20-Year Observational Study
por: Konrad Rejdak, et al.
Publicado: (2021)

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
por: Bortolato B, et al.
Publicado: (2015)

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies
por: Mathews M, et al.
Publicado: (2020)

Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
por: Rachit Sharma, et al.
Publicado: (2021)

Schizophrenia and sleep disorders: links, risks, and management challenges
por: Kaskie RE, et al.
Publicado: (2017)

Pictorial size perception in schizophrenia
por: Maria Lúcia de Bustamante Simas, et al.
Publicado: (2021)

Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
por: Lena Palaniyappan, et al.
Publicado: (2021)

Influence of sex on outcomes after percutaneous coronary intervention in patients over 75 years of age with coronary heart disease
por: Liu Y, et al.
Publicado: (2014)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019)

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
por: Saragoussi D, et al.
Publicado: (2017)

Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics
por: Li N, et al.
Publicado: (2018)

One patient with Sjogren’s syndrome presenting schizophrenia-like symptoms
por: Lin CE
Publicado: (2016)

Design and pilot evaluation of an evidence-based worksheet and clinician guide to facilitate nutrition counselling for patients with severe mental illness
por: Laura LaChance, et al.
Publicado: (2021)

Evolution of memory system‐related genes
por: Amal Bajaffer, et al.
Publicado: (2021)